Optimizing Vancomycin dosing in a sample of critically ill patients comparing current practices to individualized dose regimen: A Randomized study.
Background:In 2020, a revised consensus guideline of therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections was published, and reviewed by many regulatory authorities Stated that, in patients with suspected or definitive serious MRSA infections, an in...
| Publicado en: | Pharmacy Practice (1886-3655) Vol. 24; no. 2; pp. 1 - 10 |
|---|---|
| Autores principales: | , , |
| Formato: | pictorial research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas S.L.
Apr-Jun2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |